Epidiolex (cannabidiol) — CareFirst (Caremark)
Seizures associated with Dravet syndrome (DS)
Initial criteria
- Member has a diagnosis of Lennox-Gastaut syndrome, Dravet syndrome, or tuberous sclerosis complex
- Member age ≥ 1 year
Reauthorization criteria
- Member is 1 year of age or older
- Member has achieved or maintained a positive clinical response (e.g., decrease in seizure frequency)
Approval duration
12 months